Tailored Drug Delivery Platforms: Stimulus‐Responsive Core–Shell Structured Nanocarriers

Abstract

Core‐shell structured nanocarriers have come into the scientific spotlight in recent years due to their intriguing properties and wide applications in materials chemistry, biology, and biomedicine. Tailored core‐shell structures to achieve desired performances has emerged as a research frontier in the development of smart drug delivery system. However, a systematic review on the design and loading/release mechanisms of stimulus‐responsive core‐shell structured nanocarriers is seldom available. This review starts with the categories of core‐shell structured nanocarriers with different means of drug payload, and then highlights the controlled release mechanism realized through stimulus‐response processes triggered under different environments. Finally, some multifaceted perspectives on the design of core‐shell structured materials as drug carriers are addressed. We hope this review could provide new enlightenments and prospects in the drug delivery field for further developing advanced and smart nanocarriers.This article is protected by copyright. All rights reserved

Advancements in Stimulus-Responsive Co-Delivery Nanocarriers for Enhanced Cancer Immunotherapy

“…15,16 Stimulus-responsive nanocarriers possess favorable attributes for the construction of a drug-delivery platform through the combination of ICD inducers and PD-1/PD-L1 inhibitors. Attributes as follows: (i) introduction of stimulus-responsive materials to reconstruct TEM, which is conducive to the acquisition of long-term immune memory after the release of ICD inducers and PD-1/PD-L1 inhibitors; 17 (ii) unifying ICD inducers and PD-1/PD-L1 inhibitors with different distributions and different targets in vivo in nanocarrier to obtain better synergistic antitumor effect; 18 (iii) avoiding the systemic toxic side effects of ICD inducers and PD-1/PD-L1 inhibitors alone; 19 and (iv) controlling the release of ICD inducers and PD-1/PD-L1 inhibitors and exerting synergistic antitumor effects. 20 In the past few years, our group has published several papers in the field of stimulus-responsive nanocarriers and accumulated some experience, which effectively provided technical support for the writing of this review.…”

Metal–Organic Frameworks-Based Nanoplatform for Treatment of Breast Cancer

“…Recently, with the development of nanomaterial architectures, a class of MOF nanostructure, MOF-on-MOF, has gathered considerable interest. , MOF-on-MOF nanocomposites are predominantly formed through growing guest MOF onto presynthesized host MOF with identical or diverse architectures, creating core–shell, hollow multishell, yolk–shell, core–satellite, or asymmetric structures. , Compared to traditional MOF, MOF-on-MOF composites have demonstrated improved performance in gas adsorption/separation, detection, and catalysis. , In drug delivery systems, core–shell nanoparticles have major advantages over simple nanoparticles leading to the improvement of properties including decreased cytotoxicity, enhanced dispersibility, biocompatibility, strengthened affinity with biomolecules and drugs due to improved surface properties, and enhanced thermal and chemical stability. − …”

Polymersomes as Innovative, Stimuli-Responsive Platforms for Cancer Therapy

“…The development of stimulus-triggered drug carrier systems, which integrate stimulus-responsive components with the therapeutic agents, represents a strategic innovation aimed at achieving precise and timely drug delivery [ 4 , 5 , 6 ]. This approach is responsive to both internal (e.g., pH, temperature, enzymes) and external (e.g., light, magnetic field) stimuli, thereby enhancing drug bioavailability and minimizing the adverse effects associated with chemotherapy [ 5 , 6 ].…”